Moxidectin: adverse event reports in all combinations
Active ingredient, alone and in combinations
Brand names with this ingredient: ProHeart, Advantage Multi, Coraxis, Simparica Trio, NexGard Plus, Credelio Quattro, and 11 more.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Read this first. FDA says this about the data:
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .
This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.
Contacting a veterinarianHow to report to FDAFDA reports received through . Counts include this ingredient alone and in combinations. Why brand names have no separate count.
From September 1997 to June 2026, FDA received 100,770 adverse event reports that name a drug with moxidectin, alone or in a combination. 7 sets of active ingredients with moxidectin have a drug page.
Of the 100,770 reports, 76,889 (76.3%) are about dogs. 11,447 reports are about cats (11.4%). In January to March 2026, FDA received 3,030 reports that name moxidectin, alone or in a combination. The signs that appear in the largest number of the 100,770 reports are "Vomiting", "Lack of efficacy (endoparasite) - heartworm" and "Lethargy". A report is not proof that a drug caused a sign.
Reports that name this ingredient rose by 31.3% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about dogs are 76.3% of the reports that name this ingredient, and 72.6% of all reports.
Reports in the latest closed quarter
| Species | Jan to Mar 2026 | Oct to Dec 2025 | Jan to Mar 2025 |
|---|---|---|---|
| All species | 3,030 | 2,868 | 2,045 |
| Dog | 2,670 | 2,499 | 1,732 |
| Cat | 150 | 148 | 115 |
| Horse | 2 | 4 | 7 |
| Other or not given | 208 | 217 | 191 |
January to March 2026 is the latest closed quarter in the data.
Drug pages with moxidectin
A report names a drug by its set of active ingredients. Each set with moxidectin that has a drug page is in the table, in order of name. The table has 7 sets.
| Active ingredients | Reports, all years | Reports, latest 12 months |
|---|---|---|
| Afoxolaner + Moxidectin + Pyrantel Pamoate | 10,096 | 4,386 |
| Fluralaner + Moxidectin | 3,964 | 687 |
| Imidacloprid + Moxidectin | 23,348 | 482 |
| Lotilaner + Moxidectin + Praziquantel + Pyrantel Pamoate | 3,399 | 2,951 |
| Moxidectin | 58,630 | 4,428 |
| Moxidectin + Praziquantel | 560 | 11 |
| Moxidectin + Pyrantel Pamoate + Sarolaner | 1,191 | 373 |
A report can name more than one set, so the counts of the sets can add to more than the count of the page.
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
Signs that the reports list
A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 100,770 reports that list the sign. One report can list more than one sign and more than one drug.
The sign that is in the largest number of the reports comes first.
- Vomiting15.6%15,763 reports
- Lack of efficacy (endoparasite) - heartworm[the product did not have the expected effect: heartworm]11.2%11,270 reports
- Lethargy[unusually tired or inactive]9%9,082 reports
- Diarrhoea[diarrhea]6.5%6,509 reports
- Lack of efficacy (endoparasite) - hookworm[the product did not have the expected effect: hookworms]6%6,048 reports
- Anaphylaxis[sudden severe allergic-type reaction]5.1%5,187 reports
- Facial swelling4.7%4,772 reports
- Pruritus[itching]4.1%4,175 reports
- Anorexia[not eating]3.8%3,784 reports
- Lack of efficacy (ectoparasite) - flea[the product did not have the expected effect: fleas]3.6%3,613 reports
- Hives3.5%3,542 reports
- Ineffective, heartworm larvae[legacy FDA term: the product did not have the expected effect (heartworm larvae)]3.2%3,199 reports
- Behavioural disorder NOS[behaviour change, type not specified]3%3,062 reports
- Depression[dull, quiet or withdrawn]3%3,045 reports
Show the next 16 signs
- Ataxia[unsteady, uncoordinated movement]2.9%2,924 reports
- Lack of efficacy (endoparasite) - roundworm NOS[the product did not have the expected effect: roundworms]2.8%2,838 reports
- Death2.7%2,720 reports
- Seizure NOS[seizure, type not specified]2.5%2,500 reports
- Hypersalivation[drooling]2.4%2,394 reports
- Fever2.3%2,290 reports
- Pale mucous membrane[pale gums]2.1%2,105 reports
- Urticaria[hives]2%2,012 reports
- Other abnormal test result NOS[abnormal laboratory result, type not specified]1.9%1,894 reports
- Lack of efficacy (endoparasite) - NOS[the product did not have the expected effect: target not specified]1.8%1,835 reports
- Lack of efficacy (endoparasite) - tapeworm[the product did not have the expected effect: tapeworms]1.7%1,686 reports
- Death by euthanasia[the animal was euthanized]1.6%1,637 reports
- Medication error NOS[a mistake in giving the product, type not specified]1.6%1,587 reports
- Weight loss1.5%1,550 reports
- Facial oedema[swollen face]1.5%1,540 reports
- Panting1.5%1,498 reports
Reports by species
Reports for each month, Jul 2021 to Jun 2026
The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
Reports by year
- Dog
- Cat
- Horse
- Other or not given
| Year | Dog | Cat | Horse | Other or not given | All species |
|---|---|---|---|---|---|
| 2026 | 5,896 | 343 | 4 | 483 | 6,726 |
| 2025 | 10,010 | 698 | 19 | 1,017 | 11,744 |
| 2024 | 7,366 | 685 | 22 | 820 | 8,893 |
| 2023 | 4,778 | 679 | 21 | 497 | 5,975 |
| 2022 | 4,404 | 684 | 28 | 371 | 5,487 |
| 2021 | 5,359 | 715 | 37 | 416 | 6,527 |
| 2020 | 5,932 | 855 | 17 | 630 | 7,434 |
| 2019 | 4,765 | 500 | 27 | 757 | 6,049 |
| 2018 | 3,189 | 587 | 27 | 506 | 4,309 |
| 2017 | 2,894 | 736 | 16 | 440 | 4,086 |
| 2016 | 2,241 | 542 | 33 | 395 | 3,211 |
| 2015 | 2,270 | 562 | 39 | 327 | 3,198 |
| 2014 | 2,486 | 554 | 36 | 360 | 3,436 |
| 2013 | 2,118 | 603 | 30 | 344 | 3,095 |
| 2012 | 1,939 | 615 | 18 | 320 | 2,892 |
| 2011 | 1,355 | 577 | 20 | 282 | 2,234 |
| 2010 | 1,001 | 532 | 26 | 241 | 1,800 |
| 2009 | 625 | 503 | 20 | 182 | 1,330 |
| 2008 | 336 | 290 | 22 | 145 | 793 |
| 2007 | 277 | 176 | 29 | 157 | 639 |
| 2006 | 51 | 3 | 34 | 135 | 223 |
| 2005 | 317 | 1 | 40 | 130 | 488 |
| 2004 | 2,407 | 1 | 45 | 135 | 2,588 |
| 2003 | 1,787 | 2 | 51 | 395 | 2,235 |
| 2002 | 2,230 | 0 | 56 | 209 | 2,495 |
| 2001 | 656 | 0 | 115 | 269 | 1,040 |
| 2000 | 54 | 1 | 157 | 211 | 423 |
| 1999 | 67 | 2 | 202 | 193 | 464 |
| 1998 | 70 | 1 | 433 | 316 | 820 |
| 1997 | 9 | 0 | 114 | 13 | 136 |
2026 has the reports that FDA received through Jun 2026. Download the years (CSV)
What the reports record
Outcome at the time of the report
- Recovered/Normal20.1%20,205
- Recovered with Sequela[recovered, with a lasting effect]0.1%119
- Ongoing35.4%35,675
- Died3.4%3,451
- Euthanized1.1%1,081
- Outcome Unknown19.7%19,834
An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 100,770 reports that name moxidectin.
Kind of report
- Safety issue61.4%61,843
- Lack of expected effectiveness25.4%25,578
- Both safety and lack of expected effectiveness4.4%4,479
- Manufacturing or product defect8.6%8,694
- Other0.2%176
Age of the animal
- Under 1 year9.1%9,124
- 1 to 3 years35.1%35,321
- 4 to 7 years23.1%23,284
- 8 to 11 years12.6%12,655
- 12 years and over6.2%6,233
- Age not given14%14,153
Each share of kind and age is of the 100,770 reports that name moxidectin.
Approved animal drugs with this active ingredient (FDA Green Book)
This section is reference data. It has no report count.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Brand names
- ProHeart
- Advantage Multi
- Coraxis
- Simparica Trio
- NexGard Plus
- Credelio Quattro
- Imoxi
- Parasedge Multi
- Midamox
- Barrier
- MoxiCloprid
- Quest
The Green Book has 5 more brand names with this active ingredient. Brand names A to Z
What the Green Book records give
- Applications with an approval in force
- 31
- Approved species
- Dogs, Cats, Cattle, Ferrets, Equids, Sheep
- Dose forms
- Topical Solution, Solution, Chewable Tablets, Liquid (Solution), Gel, Injectable Solution, Microspheres, Sterile suspension, Tablet
- Routes
- Topical, Oral, Subcutaneous, Transdermal
- Sale
- RX (prescription), OTC (over the counter)
- Earliest approval date in the records
The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.
| Brand name | Active ingredients | Sponsor | Approved species | Application |
|---|---|---|---|---|
| ProHeart | Moxidectin | Zoetis Inc. | Dogs | NADA 141-051 |
| Quest Gel | Moxidectin | Zoetis Inc. | Horses | NADA 141-087 |
| Cydectin (moxidectin) Pour-On for Beef and Dairy Cattle | Moxidectin | Elanco US Inc. | Cattle | NADA 141-099 |
| ProHeart 6 | Moxidectin | Zoetis Inc. | Dogs | NADA 141-189 |
| Quest Plus Gel | Moxidectin, Praziquantel | Zoetis Inc. | Horses | NADA 141-216 |
| Cydectin | Moxidectin | Elanco US Inc. | Cattle | NADA 141-220 |
| Cydectin Oral Drench for Sheep | Moxidectin | Elanco US Inc. | Sheep | NADA 141-247 |
| Advantage Multi for Dogs | Imidacloprid, Moxidectin | Elanco US Inc. | Dogs | NADA 141-251 |
| Advantage multi for cats | Imidacloprid, Moxidectin | Elanco US Inc. | Cats | NADA 141-254 |
| Coraxis | Moxidectin | Elanco US Inc. | Dogs | NADA 141-417 |
| Bravecto Plus | Fluralaner, Moxidectin | Intervet, Inc. | Cats | NADA 141-518 |
| ProHeart 12 | Moxidectin | Zoetis Inc. | Dogs | NADA 141-519 |
| Simparica Trio | Moxidectin, Pyrantel Pamoate, Sarolaner | Zoetis Inc. | Dogs | NADA 141-521 |
| NexGard Plus | Afoxolaner, Moxidectin, Pyrantel Pamoate | Boehringer Ingelheim Animal Health USA, Inc. | Dogs | NADA 141-554 |
| Credelio Quattro | Lotilaner, Moxidectin, Praziquantel, Pyrantel Pamoate | Elanco US Inc. | Dogs | NADA 141-581 |
| Credelio Quattro-CA1 | Lotilaner, Moxidectin, Praziquantel, Pyrantel Pamoate | Elanco US Inc. | Dogs | NADA 141-619 |
| Imoxi Topical Solution for Dogs | Imidacloprid, Moxidectin | Vetoquinol USA, Inc. | Dogs | ANADA 200-615 |
| Imoxi Topical Solution for Cats | Imidacloprid, Moxidectin | Vetoquinol USA, Inc. | Cats | ANADA 200-638 |
| Parasedge Multi for Dogs | Imidacloprid, Moxidectin | Virbac AH, Inc. | Dogs | ANADA 200-700 |
| Parasedge Multi for Cats | Imidacloprid, Moxidectin | Virbac AH, Inc. | Cats | ANADA 200-701 |
| Barrier for cats | Imidacloprid, Moxidectin | Aurora Pharmaceutical, Inc. | Cats | ANADA 200-714 |
| Midamox for Dogs | Imidacloprid, Moxidectin | Norbrook Laboratories, Ltd. | Dogs | ANADA 200-716 |
| Barrier for dogs | Imidacloprid, Moxidectin | Aurora Pharmaceutical, Inc. | Dogs | ANADA 200-718 |
| Midamox for Cats | Imidacloprid, Moxidectin | Norbrook Laboratories, Ltd. | Cats | ANADA 200-721 |
| Tauramox | Moxidectin | Norbrook Laboratories, Ltd. | Cattle | ANADA 200-746 |
| MoxiSolv Injection | Moxidectin | Bimeda Animal Health Ltd. | Cattle | ANADA 200-788 |
| MoxiCloprid for Cats | Imidacloprid, Moxidectin | Bimeda Animal Health Ltd. | Cats | ANADA 200-811 |
| MoxiCloprid for Dogs | Imidacloprid, Moxidectin | Bimeda Animal Health Ltd. | Dogs | ANADA 200-818 |
| MoxiShield | Moxidectin | Virbac AH, Inc. | Cattle | ANADA 200-836 |
| MoxiSolv Pour-On | Moxidectin | Bimeda Animal Health Ltd. | Cattle | ANADA 200-845 |
| Moxidectin Oral Drench for Sheep | Moxidectin | First Priority, Inc. | Sheep | ANADA 200-852 |
FDA pages for this ingredient
- How to Report Animal Drug and Device Side Effects and Product ProblemsThe FDA page that tells an owner or a veterinarian how to send a report.
- Green Book record of NADA 141-051The FDA record of the application for ProHeart.
- Green Book record of NADA 141-189The FDA record of the application for ProHeart 6.Client Information Sheet of ProHeart 6 (PDF): a label document that FDA posts with the record.Package Insert of ProHeart 6 (PDF): a label document that FDA posts with the record.
- Green Book record of NADA 141-251The FDA record of the application for Advantage Multi for Dogs.
- Green Book record of NADA 141-417The FDA record of the application for Coraxis.
- Green Book record of NADA 141-519The FDA record of the application for ProHeart 12.Client Information Sheet of ProHeart 12 (PDF): a label document that FDA posts with the record.Package Insert of ProHeart 12 (PDF): a label document that FDA posts with the record.
- Green Book record of NADA 141-521The FDA record of the application for Simparica Trio.
- Animal Drugs @ FDAThe search page of the Green Book, the FDA list of approved animal drugs.
The site checked these addresses on . The links open in a new tab.
Cite this page
Pet Drug Reports. Moxidectin, all combinations: adverse event reports that FDA received. https://petdrugreports.com/ingredient/moxidectin/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .
Where the data come from
The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. Ingredient names follow the Green Book, with salts and forms as FDA lists them.
The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.
Questions about these reports
- Which brand are these reports about?
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists brand names with this active ingredient.
- Do the reports show that the ingredient caused the signs?
No. A report can name more than one drug, and a drug can have more than one active ingredient. FDA states this about the data.
When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.
The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
- How many reports did FDA receive in the latest 12 months?
FDA received 13,072 reports in the 12 months to June 2026. It received 9,955 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
- What kinds of report are in the count?
Of the 100,770 reports received from September 1997 to June 2026, 61.4% are about a safety issue only. 29.8% are about a lack of expected effectiveness, alone or with a safety issue. 8.6% are about a defect of the product or its package.